Samsung Biologics (207940)
삼성바이오로직스 KOSPI 기초 의약물질 제조업
Close (Aug 19, 2026)
₩1,544,000
+0.85%
Market cap
₩71T ($50.7B)
52-week range
– –
₩1,987,000
P/E · P/B · Div yield
57.98 · 9.58 ·
0%
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-08-19 | ₩1,544,000 | +₩4.8bn | +₩1.9bn | ₩-6.7bn |
| 2026-08-18 | ₩1,531,000 | +₩1.2bn | ₩-1.6bn | +₩0.7bn |
| 2026-08-14 | ₩1,548,000 | ₩-1.9bn | ₩-10.8bn | +₩13.0bn |
| 2026-08-13 | ₩1,564,000 | +₩38.3bn | ₩-39.4bn | +₩2.4bn |
| 2026-08-12 | ₩1,549,000 | +₩8.8bn | ₩-22.8bn | +₩15.0bn |
| 2026-08-11 | ₩1,609,000 | +₩25.6bn | +₩26.7bn | ₩-49.6bn |
| 2026-08-10 | ₩1,569,000 | +₩15.9bn | +₩1.0bn | ₩-17.8bn |
| 2026-08-07 | ₩1,556,000 | +₩20.2bn | +₩20.1bn | ₩-36.7bn |
| 2026-08-06 | ₩1,514,000 | +₩18.1bn | +₩1.4bn | ₩-18.6bn |
| 2026-08-05 | ₩1,491,000 | +₩25.6bn | ₩-13.8bn | ₩-11.6bn |
| 2026-08-04 | ₩1,476,000 | +₩28.6bn | ₩-12.3bn | ₩-15.5bn |
| 2026-08-03 | ₩1,423,000 | ₩-0.0bn | ₩-21.8bn | +₩20.8bn |
| 2026-07-31 | ₩1,485,000 | ₩-7.1bn | ₩-31.3bn | +₩35.4bn |
| 2026-07-30 | ₩1,527,000 | +₩2.2bn | +₩28.4bn | ₩-26.2bn |
| 2026-07-29 | ₩1,479,000 | ₩-12.1bn | +₩33.6bn | ₩-20.8bn |
| 2026-07-28 | ₩1,549,000 | ₩-24.8bn | +₩82.5bn | ₩-50.6bn |
| 2026-07-27 | ₩1,545,000 | ₩-7.9bn | +₩47.5bn | ₩-40.6bn |
| 2026-07-24 | ₩1,518,000 | +₩115.1bn | +₩112.0bn | ₩-220.8bn |
| 2026-07-23 | ₩1,379,000 | ₩-8.2bn | ₩-2.5bn | +₩10.4bn |
| 2026-07-22 | ₩1,372,000 | +₩2.7bn | ₩-1.6bn | ₩-1.4bn |
| 2026-07-21 | ₩1,395,000 | ₩-0.2bn | +₩16.1bn | ₩-15.6bn |
| 2026-07-20 | ₩1,345,000 | ₩-18.8bn | +₩6.2bn | +₩8.0bn |
| 2026-07-16 | ₩1,396,000 | +₩3.8bn | +₩3.2bn | ₩-6.7bn |
| 2026-07-15 | ₩1,383,000 | +₩24.0bn | ₩-14.1bn | ₩-9.1bn |
| 2026-07-14 | ₩1,368,000 | ₩-6.1bn | +₩2.2bn | +₩3.9bn |
| 2026-07-13 | ₩1,400,000 | +₩5.0bn | +₩17.8bn | ₩-22.3bn |
| 2026-07-10 | ₩1,395,000 | +₩22.8bn | +₩3.1bn | ₩-26.1bn |
| 2026-07-09 | ₩1,325,000 | ₩-2.9bn | +₩4.1bn | ₩-2.5bn |
| 2026-07-08 | ₩1,363,000 | ₩-5.4bn | +₩6.2bn | +₩0.4bn |
| 2026-07-07 | ₩1,422,000 | +₩1.0bn | +₩21.5bn | ₩-22.2bn |
| 2026-07-06 | ₩1,405,000 | ₩-5.1bn | +₩1.0bn | +₩4.3bn |
| 2026-07-03 | ₩1,421,000 | +₩4.8bn | +₩10.4bn | ₩-15.6bn |
| 2026-07-02 | ₩1,406,000 | +₩21.5bn | +₩20.2bn | ₩-36.1bn |
| 2026-07-01 | ₩1,396,000 | ₩-4.2bn | +₩2.0bn | +₩2.1bn |
| 2026-06-30 | ₩1,391,000 | +₩8.2bn | ₩-21.6bn | +₩12.1bn |
| 2026-06-29 | ₩1,448,000 | +₩35.8bn | +₩16.6bn | ₩-53.2bn |
| 2026-06-26 | ₩1,343,000 | ₩-1.7bn | ₩-1.9bn | +₩4.6bn |
| 2026-06-25 | ₩1,386,000 | +₩22.0bn | ₩-9.2bn | ₩-15.3bn |
| 2026-06-24 | ₩1,385,000 | +₩33.1bn | +₩3.0bn | ₩-35.4bn |
| 2026-06-23 | ₩1,273,000 | +₩20.9bn | ₩-0.7bn | ₩-22.4bn |
| 2026-06-22 | ₩1,295,000 | ₩-12.9bn | ₩-20.1bn | +₩31.9bn |
| 2026-06-19 | ₩1,374,000 | +₩6.8bn | ₩-15.0bn | +₩8.3bn |
| 2026-06-18 | ₩1,430,000 | +₩42.6bn | ₩-6.8bn | ₩-34.6bn |
| 2026-06-17 | ₩1,370,000 | +₩20.5bn | ₩-7.6bn | ₩-13.0bn |
| 2026-06-16 | ₩1,333,000 | ₩-4.0bn | ₩-0.3bn | +₩4.4bn |
| 2026-06-15 | ₩1,332,000 | +₩4.7bn | ₩-6.9bn | +₩2.4bn |
| 2026-06-12 | ₩1,295,000 | +₩7.6bn | ₩-16.4bn | +₩9.1bn |
| 2026-06-11 | ₩1,286,000 | +₩23.2bn | ₩-23.3bn | ₩-0.1bn |
| 2026-06-10 | ₩1,298,000 | +₩6.0bn | +₩0.4bn | ₩-5.8bn |
| 2026-06-09 | ₩1,296,000 | +₩13.0bn | ₩-7.6bn | ₩-6.7bn |
| 2026-06-08 | ₩1,243,000 | +₩1.4bn | ₩-33.3bn | +₩28.0bn |
| 2026-06-05 | ₩1,340,000 | ₩-11.4bn | +₩6.8bn | +₩5.3bn |
| 2026-06-04 | ₩1,350,000 | +₩5.0bn | ₩-2.8bn | +₩9.5bn |
| 2026-06-02 | ₩1,367,000 | +₩11.4bn | ₩-4.9bn | ₩-0.1bn |
| 2026-06-01 | ₩1,377,000 | +₩6.8bn | ₩-0.0bn | ₩-6.9bn |
| 2026-05-29 | ₩1,363,000 | +₩14.2bn | ₩-18.5bn | +₩5.9bn |
| 2026-05-28 | ₩1,373,000 | +₩3.6bn | ₩-4.2bn | ₩-0.2bn |
| 2026-05-27 | ₩1,384,000 | ₩-5.4bn | ₩-15.1bn | +₩20.6bn |
| 2026-05-26 | ₩1,425,000 | ₩-0.9bn | ₩-4.8bn | +₩5.1bn |
| 2026-05-22 | ₩1,415,000 | +₩3.6bn | ₩-17.7bn | +₩12.5bn |
| 2026-05-21 | ₩1,395,000 | +₩16.3bn | ₩-12.0bn | ₩-3.7bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | +₩4.8bn | +$3M | +₩1.9bn | ₩-6.7bn |
| 5 days | +₩51.1bn | +$36M | ₩-72.8bn | +₩24.4bn |
| 20 days | +₩244.9bn | +$174M | +₩197.3bn | ₩-419.1bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | ₩3.7T ($2.6B) | – | ₩1.1T ($790M) | ₩858bn ($608M) |
| 2024 | ₩4.5T ($3.2B) | +23.10% | ₩1.3T ($936M) | ₩1.1T ($768M) |
| 2025 | ₩4.6T ($3.2B) | +0.20% | ₩2.1T ($1.5B) | ₩1.8T ($1.3B) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1410.07/$) for reference only.